SCHEMBL16618533

SCHEMBL16618533

CN(C(=O)c1ccc(-c2ccccc2)cc1)S(C)(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
HSD11B1 P28845 1/20 0.54
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
USP2 O75604 1/20 0.50
AGTR1 P30556 1/20 0.47
OXTR P30559 1/20 0.47
GAA P10253 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PTPN1 P18031 1/20 0.46
GSK3B P49841 1/20 0.46
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
MEN1 O00255 1/20 0.43
ALOX12 P18054 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134145 0.89 HSD11B1 (0.67) ALDH1A1HPGDHSD11B1KDM4EL3MBTL1
SCHEMBL2047793 0.79 HPGD (0.63) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL24992899 0.78 HSD11B1 (0.44) MAPTALDH1A1HPGDHSD11B1SMN1; SMN2
SCHEMBL23169174 0.77 MAPT (0.61) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL5858450 0.76 MAPT (0.59) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL7736889 0.75 CES2 (0.52) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL2469395 0.74 KMT2A (0.66) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL30268201 0.74 NPSR1 (0.66) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL9001632 0.74 OXTR (0.64) MAPTALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL16291493 0.74 KMT2A (0.51) ALDH1A1HPGDHSD11B1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015051043-A1 BIARYL ACYL-SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS AMGEN INC. (US) 2015-04-09 WO disclosed